A Phase 1 Study of UB-VV500 With Rapamycin in Relapsed/Refractory Multiple Myeloma

Clinical trial NCT07735546 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07735546
Sponsor: Umoja Biopharma
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Multiple Myeloma (MM)

Start date: 2026-10-01
Primary completion: 2029-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.